The implementation of the National Cancer Strategy is a Programme for Government commitment and is part of the implementation of Sláintecare. We have seen significant progress on the implementation of the Strategy in recent years, with clear evidence-based policy direction from my Department and strong implementation by the HSE's National Cancer Control Programme (NCCP).
Funding of €20m new development funding was allocated for implementing the recommendations of the National Cancer Strategy in 2021. In addition, €10m was allocated for cancer screening services and €15m for new cancer drugs. As part of Budget 2022, a further €20m in new development funding has been allocated for implementation of the Strategy and €15m for new cancer drugs. This funding is being used to support ongoing initiatives and to drive improvements across all stages of the cancer continuum – facilitating further developments across prevention, diagnosis, treatment and patient supports.